Teleflex (NYSE:TFX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Teleflex (NYSE:TFX) in the last three months. The table below provides a snapshot of their ...

Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 28.5% year on year to $569 million. Its non-GAAP profit of $1.93 per share was ...

Teleflex ( (TFX)) has issued an update. Teleflex Incorporated reported a 2.4% increase in GAAP revenue for Q3 2024, reaching $764.4 million, with strong contributions from Interventional and Vascular ...

A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in ...

Investing.com - Needham raised its price target on Teleflex Inc. shares (NYSE:TFX) to $147 from $138 while maintaining a Buy rating on the stock. The shares currently trade at $119.63, and ...

GAMMA Investing LLC lessened its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 21.4% during the first quarter, according to its most recent filing with the Securities & ...

Natixis Advisors LLC lowered its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 37.0% during the fourth quarter, according to the company in its most recent Form 13F filing ...